Faculty of Medicine, Department of Ophthalmology, Başkent University, Ankara, Turkey.
Faculty of Medicine, Department of Neurology, Başkent University, Ankara, Turkey.
Ocul Immunol Inflamm. 2022 Jul;30(5):1255-1259. doi: 10.1080/09273948.2022.2055578. Epub 2022 Apr 11.
To report a case of transient visual field (VF) defect after coronavirus disease-19 (COVID-19) vaccination.
A 38-year-old Caucasian, otherwise healthy female patient, presented with a complaint of vision loss in the outer quadrant in her left eye after the second dose of Pfizer®-BioNTech™ COVID-19 vaccine. The Snellen visual acuity was 20/20 in both eyes. She did not have relative afferent pupillary defect nor disturbance of color vision. Her intraocular pressures, slit lamp and fundus examinations were normal. In the VF test, a temporal hemifield defect in the left eye and a nasal peripheral VF defect in the right eye were detected. Other imaging characteristics and neurological examination were normal. She was followed without any treatment. One week later, the patient was re-evaluated and complete resolution of the VF defect was observed.
Clinicians should be aware that patients can experience transient visual symptoms following COVID-19 vaccination.
报告一例接种新冠肺炎（COVID-19）疫苗后出现短暂视野（VF）缺损的病例。
一名 38 岁的白人健康女性患者，在接种辉瑞-生物科技（Pfizer-BioNTech） COVID-19 疫苗第二剂后，左眼出现外象限视力丧失。双眼视力均为 20/20。她没有相对性传入性瞳孔障碍，也没有色觉障碍。她的眼压、裂隙灯和眼底检查均正常。在视野检查中，左眼出现颞侧视野缺损，右眼出现鼻侧周边视野缺损。其他影像学特征和神经系统检查均正常。她未接受任何治疗，仅进行了随访。一周后，患者再次接受评估，发现视野缺损完全消失。
临床医生应注意到，患者在接种 COVID-19 疫苗后可能会出现短暂的视觉症状。
